BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15170155)

  • 1. Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature.
    Andreopoulou E; Pectasides D; Dimopoulos MA; Nikolaides C; Fountzilas G; Valsami S; Economopoulos T
    Am J Clin Oncol; 2004 Jun; 27(3):312-6. PubMed ID: 15170155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
    Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
    Zinzani PL; Martelli M; Bertini M; Gianni AM; Devizzi L; Federico M; Pangalis G; Michels J; Zucca E; Cantonetti M; Cortelazzo S; Wotherspoon A; Ferreri AJ; Zaja F; Lauria F; De Renzo A; Liberati MA; Falini B; Balzarotti M; Calderoni A; Zaccaria A; Gentilini P; Fattori PP; Pavone E; Angelopoulou MK; Alinari L; Brugiatelli M; Di Renzo N; Bonifazi F; Pileri SA; Cavalli F;
    Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary mediastinal large B-cell lymphoma:a report of 24 cases with literature review].
    Chen DG; Yang Y; Pan CZ
    Ai Zheng; 2008 Feb; 27(2):187-90. PubMed ID: 18279619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.
    Sarkozy C; Molina T; Ghesquières H; Michallet AS; Dupuis J; Damotte D; Morsschauser F; Parrens M; Martin L; Dartigues P; Stamatoullas A; Hirsch P; Fabiani B; Bouabdallah K; da Silva MG; Maerevoet M; Laurent C; Coiffier B; Salles G; Traverse-Glehen A
    Haematologica; 2017 Jan; 102(1):150-159. PubMed ID: 27758822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
    Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
    Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinal large-cell lymphoma with sclerosis (MLCLS).
    Rohatiner AZ; Whelan JS; Ganjoo RK; Norton AJ; Wilson A; Lister TA
    Br J Cancer; 1994 Mar; 69(3):601-4. PubMed ID: 8123496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary mediastinal large B-cell lymphoma.
    Savage KJ
    Oncologist; 2006 May; 11(5):488-95. PubMed ID: 16720849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
    Abou-Elella AA; Weisenburger DD; Vose JM; Kollath JP; Lynch JC; Bast MA; Bierman PJ; Greiner TC; Chan WC; Armitage JO
    J Clin Oncol; 1999 Mar; 17(3):784-90. PubMed ID: 10071267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I treat primary mediastinal B-cell lymphoma.
    Giulino-Roth L
    Blood; 2018 Aug; 132(8):782-790. PubMed ID: 29976557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
    Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
    J Clin Oncol; 1998 Jan; 16(1):63-9. PubMed ID: 9440724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mediastinal large B-cell lymphoma: a single-center study of clinicopathologic characteristics.
    Kolonić SO; Dzebro S; Kusec R; Planinc-Peraica A; Dominis M; Jaksić B
    Int J Hematol; 2006 May; 83(4):331-6. PubMed ID: 16757434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary mediastinal B-cell lymphoma.
    Boleti E; Johnson PW
    Hematol Oncol; 2007 Dec; 25(4):157-63. PubMed ID: 17575573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.
    Cazals-Hatem D; Lepage E; Brice P; Ferrant A; d'Agay MF; Baumelou E; Brière J; Blanc M; Gaulard P; Biron P; Schlaifer D; Diebold J; Audouin J
    Am J Surg Pathol; 1996 Jul; 20(7):877-88. PubMed ID: 8669537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.
    Lazzarino M; Orlandi E; Paulli M; Boveri E; Morra E; Brusamolino E; Kindl S; Rosso R; Astori C; Buonanno MC
    J Clin Oncol; 1993 Dec; 11(12):2306-13. PubMed ID: 8246020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.
    Lazzarino M; Orlandi E; Paulli M; Sträter J; Klersy C; Gianelli U; Gargantini L; Rousset MT; Gambacorta M; Marra E; Lavabre-Bertrand T; Magrini U; Manegold C; Bernasconi C; Möller P
    J Clin Oncol; 1997 Apr; 15(4):1646-53. PubMed ID: 9193365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma.
    Yang SH; Hsiao LT; Chiou TJ; Yang CF; Yu YB; Liu CY; Gau JP; Liu JH; Chen PM; Tzeng CH
    J Chin Med Assoc; 2015 Jul; 78(7):400-7. PubMed ID: 25801492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
    De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mediastinal large B-cell lymphoma.
    Martelli M; Ferreri A; Di Rocco A; Ansuinelli M; Johnson PWM
    Crit Rev Oncol Hematol; 2017 May; 113():318-327. PubMed ID: 28318892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.